At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antidepressants; Oxadiazoles; Piperazines
- Mechanism of Action Serotonin 1B receptor antagonists; Serotonin 1D receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Major depressive disorder